Rating History for Corvus Pharmaceuticals (CRVS) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for CRVS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/17/2026 Paul Choi New Coverage Buy
(N/A)		 40.00
(N/A)		 15.11
(14.76)		 -2.32% Details